CGM in Early Gestational Diabetes Improved Outcomes - Scorecard - MDSpire

CGM in Early Gestational Diabetes Improved Outcomes

  • By

  • Kathryn Wighton

  • April 22, 2026

  • 3 min

Share

Clinical Scorecard: CGM in Early Gestational Diabetes Improved Outcomes

At a Glance

CategoryDetail
ConditionGestational Diabetes
Key MechanismsContinuous glucose monitoring (CGM) vs self-monitoring of blood glucose.
Target PopulationPatients diagnosed with gestational diabetes between 8 and 26 weeks’ gestation.
Care SettingSingle-center randomized controlled trial.

Key Highlights

  • CGM did not improve time in range but improved maternal and neonatal outcomes.
  • Lower rates of preterm delivery (7% vs 18%) with CGM.
  • Higher patient satisfaction with CGM (mean score 4.3/5).
  • Fewer failed inductions leading to cesarean delivery (20% vs 44%) with CGM.
  • CGM identified more hyperglycemic episodes than self-monitoring.

Guideline-Based Recommendations

Diagnosis

  • Gestational diabetes diagnosed between 8 and 26 weeks’ gestation.

Management

  • Consider CGM for improved maternal and neonatal outcomes despite no change in time in range.

Monitoring & Follow-up

  • Monitor glucose levels continuously for better detection of glycemic excursions.

Risks

  • Potential for underpowering of study and limitations due to single-center design.

Patient & Prescribing Data

128 patients enrolled, 120 completed the study.

CGM associated with better maternal and neonatal outcomes, including fewer NICU admissions.

Clinical Best Practices

  • Utilize CGM for patients with gestational diabetes to enhance understanding of glucose levels.
  • Monitor for hyperglycemic episodes more effectively with CGM.

References

Original Source(s)

Related Content